News for hackers. Stuff that matters.
Re:SARS-CoV-2 positivity rates associated with circulating V... by tehjoker on Saturday September 19, 2020 @07:09PM (#24530897)
The "therapeutic" dose of HCQ in COVID-19 patients is usually 600mg and up. The therapeutic dose for e.g. rheumatoid arthritis is 400mg or less. These higher doses were linked to arrhythmia and very little evidence of a beneficial effect has been found.

HCQ has been used in petri dishes against many viruses and been successful there. Whenever they use it in vivo, it fails. This is not a new phenomenon. The link below is somewhat dated at this point (May 2020), but I believe it still stands.

https://www.sciencedirect.com/science/article/abs/pii/S01663...

In any case, if the FDA is saying "may not" the drug is not a slam dunk even if it has some beneficial effect. Winning the rhetorical war on HCQ isn't going to make COVID go away or be less serious in a substantial fashion.

Re:SARS-CoV-2 positivity rates associated with circulating V... by ColanR on Saturday September 19, 2020 @07:56PM (#24531067)
> Winning the rhetorical war on HCQ

You said there's "no evidence". I said you were wrong, and apparently could muster better information than you could. That's not rhetoric, that's logic and evidence.